These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 20419850)
1. Choroidal neovascular membrane in persistent fetal vasculature syndrome managed with intravitreal pegaptanib sodium in an infant. Vinekar A; Sund N; Quiram P; Capone A Retina; 2010 Apr; 30(4 Suppl):S41-4. PubMed ID: 20419850 [TBL] [Abstract][Full Text] [Related]
2. Treatment of naïve lesions in neovascular age-related macular degeneration with pegaptanib. Quiram PA; Hassan TS; Williams GA Retina; 2007 Sep; 27(7):851-6. PubMed ID: 17891008 [TBL] [Abstract][Full Text] [Related]
3. Progression of choroidal neovascularization following injection of pegaptanib sodium (macugen) in two eyes with neovascular age-related macular degeneration. Williams AJ; Fekrat S Am J Ophthalmol; 2006 Oct; 142(4):683-4. PubMed ID: 17011868 [TBL] [Abstract][Full Text] [Related]
4. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration. Joeres S; Kaplowitz K; Brubaker JW; Updike PG; Collins AT; Walsh AC; Romano PW; Sadda SR Ophthalmology; 2008 Feb; 115(2):347-354.e2. PubMed ID: 17628685 [TBL] [Abstract][Full Text] [Related]
5. Optical coherence tomography findings during pegaptanib therapy for neovascular age-related macular degeneration. Emerson GG; Flaxel CJ; Lauer AK; Stout JT; Emerson MV; Nolte S; Wilson DJ; Klein ML Retina; 2007; 27(6):724-9. PubMed ID: 17621181 [TBL] [Abstract][Full Text] [Related]
6. Treatment of Co-existent occult choroidal neovascular membrane and macular hole. Singh RP; Kaiser PK Surv Ophthalmol; 2007; 52(5):547-50. PubMed ID: 17719376 [TBL] [Abstract][Full Text] [Related]
7. RPE tears after pegaptanib treatment in age-related macular degeneration. Chang LK; Flaxel CJ; Lauer AK; Sarraf D Retina; 2007 Sep; 27(7):857-63. PubMed ID: 17891009 [TBL] [Abstract][Full Text] [Related]
8. Ranibizumab-pegaptanib therapy for idiopathic choroidal neovascularization: report of a case. Friberg TR Semin Ophthalmol; 2007; 22(3):137-9. PubMed ID: 17763232 [TBL] [Abstract][Full Text] [Related]
9. Management of CNV in angioid streaks by intravitreal use of specific anti-VEGF165 Aptamer (pegaptanib sodium): long-term results. Cekiç O; Göçmez E; Kocabora MS Curr Eye Res; 2011 May; 36(5):492-5. PubMed ID: 21501082 [TBL] [Abstract][Full Text] [Related]
10. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. ; D'Amico DJ; Masonson HN; Patel M; Adamis AP; Cunningham ET; Guyer DR; Katz B Ophthalmology; 2006 Jun; 113(6):992-1001.e6. PubMed ID: 16647134 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal pegaptanib sodium (Macugen) for treatment of myopic choroidal neovascularization: a morphologic and functional study. Rinaldi M; Chiosi F; DellʼOmo R; Romano MR; Parmeggiani F; Semeraro F; Menzione M; Costagliola C Retina; 2013 Feb; 33(2):397-402. PubMed ID: 22990315 [TBL] [Abstract][Full Text] [Related]
12. Management of pediatric choroidal neovascular membranes with intravitreal anti-VEGF agents: a retrospective consecutive case series. Kohly RP; Muni RH; Kertes PJ; Lam WC Can J Ophthalmol; 2011 Feb; 46(1):46-50. PubMed ID: 21283157 [TBL] [Abstract][Full Text] [Related]
13. [Clinical experience in the treatment of neovascular age-related macular degeneration with pegaptanib]. Maier M; Feucht N; Huebner M; Lohmann C Klin Monbl Augenheilkd; 2008 Jun; 225(6):582-7. PubMed ID: 18516780 [TBL] [Abstract][Full Text] [Related]
14. Compassionate use of intravitreal pegaptanib in patients with age-related macular degeneration. Ricci F; Missiroli F; Cedrone C; Grossi M; Regine F Semin Ophthalmol; 2010; 25(1-2):16-20. PubMed ID: 20507192 [TBL] [Abstract][Full Text] [Related]
15. Triple therapy of intravitreal triamcinolone, photodynamic therapy, and pegaptanib sodium for choroidal neovascularization. Liggett PE; Colina J; Chaudhry NA; Tom D; Haffner G Am J Ophthalmol; 2006 Dec; 142(6):1072-4. PubMed ID: 17157599 [TBL] [Abstract][Full Text] [Related]